Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

v3.10.0.1
Stockholders' Equity (Details Narrative) - USD ($)
6 Months Ended
Dec. 31, 2018
Jun. 30, 2018
Weighted average grant fair value (in dollars per share) $ 2.68  
Accrued stock compensation expenses $ 142,144 $ 395,539
Number of shares issued (in shares) 7,250,000  
Number of shares issued (in dollars per share) $ 4.25  
Gross proceeds from issuance of shares $ 30,800,000  
Commissions on issuance of shares $ 2,100,000  
Dividend yield 0.00%  
Investor [Member] | Private Placement [Member]    
Number of shares issued (in shares) 112,365  
Closing date 2017-05  
Restricted Stock Units [Member]    
Number of shares granted 494,880  
Weighted average grant fair value (in dollars per share) $ 5.95  
Vesting period 4 years  
Performance-Based Restricted Stock Units [Member]    
Number of shares granted 119,500  
Weighted average grant fair value (in dollars per share) $ 8.30  
Employees And Directors [Member]    
Number of shares granted 836,955  
Weighted average grant fair value (in dollars per share) $ 2.68